1. Home
  2. ANIP vs TPC Comparison

ANIP vs TPC Comparison

Compare ANIP & TPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
    SELLHOLDBUYas of 2 days ago
  • TPC
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • ANIP 2001
  • TPC 1894
  • Country
  • ANIP United States
  • TPC United States
  • Employees
  • ANIP N/A
  • TPC N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • TPC General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • ANIP Health Care
  • TPC Consumer Discretionary
  • Exchange
  • ANIP Nasdaq
  • TPC Nasdaq
  • Market Cap
  • ANIP 1.2B
  • TPC 1.4B
  • IPO Year
  • ANIP N/A
  • TPC N/A
  • Fundamental
  • Price
  • ANIP $53.35
  • TPC $25.63
  • Analyst Decision
  • ANIP Buy
  • TPC Strong Buy
  • Analyst Count
  • ANIP 7
  • TPC 2
  • Target Price
  • ANIP $77.33
  • TPC $39.50
  • AVG Volume (30 Days)
  • ANIP 307.4K
  • TPC 412.0K
  • Earning Date
  • ANIP 11-08-2024
  • TPC 11-06-2024
  • Dividend Yield
  • ANIP N/A
  • TPC N/A
  • EPS Growth
  • ANIP N/A
  • TPC N/A
  • EPS
  • ANIP N/A
  • TPC N/A
  • Revenue
  • ANIP $555,456,000.00
  • TPC $4,280,743,999.00
  • Revenue This Year
  • ANIP $25.48
  • TPC $13.06
  • Revenue Next Year
  • ANIP $20.24
  • TPC $14.06
  • P/E Ratio
  • ANIP N/A
  • TPC N/A
  • Revenue Growth
  • ANIP 23.60
  • TPC 13.69
  • 52 Week Low
  • ANIP $52.00
  • TPC $7.83
  • 52 Week High
  • ANIP $70.81
  • TPC $34.55
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 36.23
  • TPC 42.39
  • Support Level
  • ANIP $52.50
  • TPC $24.34
  • Resistance Level
  • ANIP $57.33
  • TPC $26.91
  • Average True Range (ATR)
  • ANIP 1.96
  • TPC 1.38
  • MACD
  • ANIP -0.41
  • TPC -0.17
  • Stochastic Oscillator
  • ANIP 10.11
  • TPC 31.39

Stock Price Comparison Chart: ANIP vs TPC

ANIP
TPC
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0510152025303540455055606570ANIP VS TPC

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. It plans and schedules the manpower, equipment, materials, and subcontractors required for a project. Tutor Perini has three operating segments: civil, building, and specialty contractors and generates majority revenue from civil segment. The company offers self-performed construction services, including site work, concrete forming, steel erection, electrical, mechanical, and heating, ventilation, and air conditioning, or HVAC. The majority of its total revenue is derived from the United States.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use